Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Greenfire Resources' (NYSE:GFR) stock is up by a considerable 5.3% over the past month. We wonder if and what role ...

A large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with type 2 diabetes, even among those with low predicted 10-year ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression sustained improvement in kidney ...

Severe valvular heart disease (VHD) is prevalent among patients with cancer and is associated with reduced survival.

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

ProKidney Corp. (NASDAQ:PROK) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, ProKidney Corp.

The need for dialysis depends on symptoms, the cause of the problem, and overall kidney function, not just one lab result ...

Introduction The UN General Assembly in 2018 passed a resolution to eliminate obstetric fistula within a decade. Because the ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney TransplantationThe application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly ...

Kidney disease often progresses silently, causing irreversible damage before symptoms appear. Simple tests like blood ...